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behavior and induce respiratory sensations”). In the other trial, a
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doi:10.1016/j.jpsychores.2008.03.019rated every 10 s, and after each trial, participants filled out a
symptom checklist. Within-subject correlations between the
subjective rating and its physiological referent were calculated
for the rebreathing phase and recovery phase of each trial
separately. Results: High symptom reporters had more (retro-
spective) complaints than low symptom reporters, especially in
the symptom trial. Only in the symptom frame were high
symptom reporters less accurate than low symptom reporters. The
reduction in interoceptive accuracy (IA) in high symptom
reporters was most striking in the recovery phase of the symptom
frame trial. Conclusion: A contextual cue, such as a reference to
symptoms, reduced IA in high symptom reporters and this was
more so during recovery from the symptom induction.
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Medically unexplained symptoms (MUS) are widespread
in modern society, implying considerable direct and indirect
costs [1]. A consistent finding across a wide variety of
measurements and populations, both nonclinical and clinical,
is a firm relationship between negative mood and negative
affect (NA) and elevated self-reports of somatic symptoms
[2–8]. Experimental manipulations inducing an aversivestimulus context (creating state NA) have been shown to
increase self-reports of pain [9–12].
Recent findings suggest that elevated self-report of
symptoms may occur in the absence of corresponding
elevated peripheral physiological activity. Houtveen et al.
[13,14] have shown in nonclinical high symptom reporters
that their self-rated somatic symptoms during mental stress,
CO2 rebreathing, or in daily life using a diary method were
unrelated to a wide variety of autonomic, ventilatory, and
cardiovascular measures. When exposed to a stressor,
anxious patients with gastroesophageal reflux report an
increased perception of reflux symptoms, despite the lack of
heightened acid reflux [15,16]. In a study with chronic
fatigue patients, imagery-induced NA was associated with a
strong increase in hyperventilation symptoms without
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[17]. Investigating the exact circumstances under which
MUS reporters perceive somatic symptoms accurately or not
requires a sound index of the within-subject correspondence
between a self-reported sensation and a clear, objective
physiological referent.
The influence of the affective context on the interoceptive
accuracy (IA) of respiratory symptoms has been documen-
ted in two recent studies of our group, administering a series
of breathing trials, containing varying concentrations of CO2
[18,19]. Determining IA as the within-subject correlation
between ratings of respiratory behavior and actual breathing
behavior, high NA persons were less accurate overall.
However, IA for breathing frequency or minute ventilation
interacted with the affective context that was created during
inhalation of the air mixtures. When it was said that the air
mixtures could induce positive sensations (like when being
in love), no NA-related difference in IAwas found, but when
the air mixtures were announced as possibly inducing
distress (like when being anxious or feeling tense), IA of
high NA persons dropped and was lower than that of low
NA persons.
The aim of the present study was to investigate IA in a
target group of nonclinical MUS reporters, using an
improved methodology compared to our previous accuracy
studies [18,19]. Firstly, by using the Rebreathing Test with
repeated online ratings within one trial rather than repeated
trials of CO2 inhalation followed by a retrospective symptom
rating, more data points on perceived sensations were
generated concurrently with the measurement of breathing
behavior. In this way, IA could be calculated from a less
time-consuming and more reliable operationalization. Sec-
ondly, in our previous studies, the affective context consisted
of an information frame and an odor manipulation. However,
odor itself may have had important effects on interoception,
which we did not control for separately. In the present study,
we only used a neutral information frame and compared it
with a symptom information frame.
We hypothesized that a contextual cue referring to
symptoms would activate an underlying schema in high
symptom reporters. This schema can be conceptualized as
the records of a personal learning history of somatic
experiences, including related beliefs and affective connota-
tions [20,21]. According to Brown [22], previous symptom
episodes, frequent exposure to physical states of others, and
verbal suggestion may create these memory traces (rogue
representations). The more consolidated the schema, the
more likely it will be triggered by associated cues. MUS arise
when the repeated activation of the schema causes the brain
to misinterpret these mental representations as current
symptom episodes, resulting in a nonvolitional and sub-
jectively convincing symptom experience.
These assumptions suggest that the presence of contextual
cues previously associated with symptom episodes may
trigger schematic memory representations in high MUS
reporters, such that symptom perception may be more guidedby the schema than by actual interoceptive feedback from
physiological responses. Thus, the presence or absence of
such contextual cues may be an important determinant of
interoception being accurate or biased in high MUS persons.
In sum, we hypothesized that, compared to a neutral
information frame, a significant decrease in IA will only
occur in high symptom reporters when placed in the
symptom information frame (the triggering context for
biased interoception). In this study, retrospective symptom
reporting will also be examined in an exploratory way.
Method
Participants
Seventy-four healthy female students (18–26 years)
participated in return for course credit or €6. The selection
of high (n=34) versus low (n=40) symptom reporters was
based on their scores on the Checklist for Symptoms in Daily
Life (see Checklist for Symptoms in Daily Life section). In a
previous pilot study on 394 female students, we determined
the upper and lower quartiles of the scores on this
questionnaire. Scores below and above these cutoff scores
were used to obtain extreme groups of low (score b75)
versus high (score N100) symptom reporters. In addition,
before the start of the experiment, participants were inquired
about their medical status to ensure that the symptoms in
daily life reported by the high MUS group could not be
attributed to a medical condition. Exclusion criteria for all
participants were based on a self-reported history of
pulmonary, cardiovascular, or neuromuscular disease or
other medical conditions that likely affect exercise capacity,
such as acute illnesses, fever, or headache. Also, participants
with major depression or any other psychiatric condition
were excluded, as well as pregnant or lactating women.
Participants were instructed to abstain from coffee, tea, or
alcoholic beverages after midnight before participating and
were asked not to smoke prior to the experiment. The
experiment was approved by the Multidisciplinary Ethical
Committee of the Department of Psychology.
Subjective measures
Questionnaires
Checklist for Symptoms in Daily Life. The Checklist for
Symptoms in Daily Life, based on Wientjes and Grossman
[23], contained the original 35 items and an additional four
dummy items (see Refs. [23,24] for components and
reliability). Examples of symptoms that are included in the
questionnaire are dizziness, joint pain, dyspnea, irregular
heartbeat, lower back pain, headache, inflated stomach, chest
pain, and so forth. Participants responded to the question “To
what extent did you experience the following symptoms over
the past year?” on a 5-point scale (never, seldom, sometimes,
often, very often).
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version of the Positive and Negative Affect Schedule
(PANAS) consists of 10 positive [positive affectivity (PA)]
and 10 negative adjectives [negative affectivity (NA)].
Participants indicate on a 5-point scale the extent to which
the items apply to their feeling right now. The reliability and
construct validity of the PANAS have been documented
[25,26].
Symptom checklist (state). Subjective complaints were
assessed by a state Symptom Checklist (46 items), based
on the Checklist for Symptoms in Daily Life ([23]; 39 items),
but adapted to the Rebreathing Test. For each symptom, a 5-
point graded intensity response (not at all, a little bit, quite,
rather strongly, very strongly) was required to the question
“To what extent do (did) you experience the following
symptoms at this moment (during the past breathing trial)?”
Concurrently perceived sensations. During each breathing
trial, a subjective sensation was rated every 10 s,
prompted by an auditory cue, on a 0–100 computerized
scale by means of a mouse click. The scale was a vertical
bar positioned in the middle of the screen. On its right,
verbal descriptors were positioned at every 10th step
describing different levels of the experienced sensation
(“dyspnea” in the symptom trial vs. “intensity of breath-
ing” in the neutral trial). Different versions were used for
the symptom/neutral information trial [none/normal inten-
sity (0); very slight (10); slight (20); moderate (30); fairly
severe (40); severe (50); very severe (60); very severe
(70); very severe (80); very, very severe (90); intolerable/
maximal (100)]. The nature and spacing of the numbers
and descriptive categories are identical to a modified
version of the CR-10 scale developed by Borg [27].
Apparatuses and physiological recordings
Participants went through two trials of the Standard
Rebreathing Test [28]. This test causes a progressive increase
of pCO2 in the blood by rebreathing from a bag, initially
filled with a 5-l gas mixture of 5% CO2 and 95% O2. By
breathing in this closed hyperoxic circuit, a state of
hypercapnia without hypoxia occurs, which compels to a
higher respiratory flow and ventilation. Participants wore
nose clips and breathed through a mouthpiece connected to a
Y-valve via a wide vinyl tube ending on a pneumotacho-
graph measuring air flow. A stopcock enabled the experi-
menter to switch the participants breathing between room air
and the rebreathing bag. Manipulations of the setup were
kept out of sight of the participants to ensure that participants
could only rely on the experienced bodily changes for their
online ratings. A small tube, connected directly to the
mouthpiece, permitted a continuous sampling of respiratory
gases. The fractional end-tidal concentration of CO2
(FetCO2) was determined using an infrared CO2 monitor.
Airflow waveforms were sampled at a rate of 20 Hz andstored on a personal computer. All waveforms were visually
inspected off-line to eliminate technical abnormalities.
Subsequently, respiratory signals were treated breath by
breath to determine the following parameters: inspiratory
time (Ti) and expiratory time (Te) in seconds, inspiratory
volume (Vi) and expiratory volume (Ve) in milliliters, and
FetCO2 in percentage. Only Vi was used as a measure of tidal
volume (Vt). We focused on FetCO2 and minute ventilation
(MV=RR×Vt), with RR (respiratory rate)=60/(Te+Ti), as
they are the closest physiological referents of the subjective
sensations experienced during the Rebreathing Test.
Procedure
The participants were invited to take part in an experiment
investigating the effect of different air mixtures on breathing
behavior and subjective well-being. Upon arrival, informed
consent was collected and participants filled out a general
health questionnaire, the PANAS state, a state Symptom
Checklist (to inquire about possible symptoms present at the
start of the experiment), and a 9-point scale on which
participants had to indicate how anxious they felt at that
moment. In addition, the participants completed the Check-
list for Symptoms in Daily Life once again. Only those
participants meeting the inclusion criterion at both moments
were included in the study (ensuring test–retest reliability).
Next, the participants were led to sit in a comfortable
chair in front of a flat screen monitor. All equipment was
placed in an adjacent room. Participants were told that they
would be inhaling different types of air mixtures. Prior to the
first breathing trial, an exercise trial (only room air) allowed
participants to become familiar with the mouthpiece, the
nose clip, and the online rating system.
Next, participants went through two breathing trials. Each
trial consisted of the same consecutive phases: baseline (60 s
of room air), rebreathing phase (150 s of rebreathing bag),
and recovery phase (150 s of room air). A 15-min intertrial
interval ensured full recovery from the trial. After each trial,
participants filled out the state Symptom Checklist (retro-
spective symptom assessment), the PANAS state, and two 9-
point scales asking about anxiety during the trial and
pleasantness of the trial (manipulation check).
The information frame was manipulated within subjects
with order counterbalanced. In the neutral frame, partici-
pants were told that the gas mixture might alter breathing
behavior and produce respiratory sensations and the online
rating scale was labeled “intensity of breathing.” Prior to
the trial, it was checked whether the participants under-
stood the meaning of the concept “intensity of breathing.”
Intenser breathing was defined as breathing faster and/or
deeper or more than at the start of the experiment. In the
symptom frame, participants were told that the gas mixture
might alter breathing behavior and induce respiratory
symptoms and complaints and the online rating scale was
labeled “dyspnea.” Prior to the trial, it was checked
whether the participants understood the meaning of the
Table 1
Mean and standard deviation for reported symptoms, state-NA, state-PA,
and state-anxiety in low versus high MUS reporters (N=74)
MUS Baseline Neutral Symptom Statistics (F; df)
State Symptom Checklist
Low MUS ⁎⁎ (54.13; 1)
Mean 50.20a 63.88b 66.40b MOM ⁎⁎ (108.03; 1.69)
S.D. 3.67 9.29 10.99 MUS×MOM ⁎ (3.36; 1.69)
High
Mean 61.82b 80.09c 85.38d
S.D. 11.48 14.25 16.04
State-NA
Low MUS ⁎⁎ (23.46; 1)
Mean 12.45a 12.63a 13.53a
S.D. 2.82 3.02 3.30
High
Mean 17.85b 17.59b 18.26b
S.D. 7.89 5.73 5.75
State-PA
Low MUS ⁎⁎ (33.91; 1)
Mean 35.45a 29.93b 29.10b MOM ⁎⁎ (77.82; 1.54)
S.D. 5.50 8.13 8.27
High
Mean 28.03b 20.09c 20.88c
S.D. 7.04 5.96 6.00
State-anxiety
Low MUS ⁎⁎ (26.18; 1)
Mean 1.78a 2.63b 3.03b MOM ⁎⁎ (25.24; 1.78)
S.D. 0.92 1.63 1.62
High
Mean 3.26b 4.12c 4.71c
S.D. 1.86 1.68 1.80
MOM, moment of measurement. Means with different superscripts are
significantly different at Pb.05.
⁎ Pb.05.
⁎⁎ Pb.01.
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feeling of not having enough air, an urge to breathe, or the
feeling of having more difficulty to breathe, compared to
the start of the experiment.
Prior to each breathing trial, it was also explained that
“the sensations/symptoms may come and go throughout the
experiment and that it would be possible not to feel any
sensations/symptoms at all.” During each breathing trial,
respiratory parameters were continuously measured.
Data analysis
Within-subject correlations were calculated between the
subjective rating and several physiological referents, sepa-
rately for the rebreathing phase and recovery phase of each
trial in order to index IA. In particular, four relationships
were inspected: intensity of breathing–FetCO2, intensity of
breathing–MV, dyspnea–FetCO2, and dyspnea–MV. A
Fisher Z transformation was carried out on all correlations
before further analysis. Reported correlations were back-
transformed from the Fisher Z scores. To control for range
restriction, we also tested possible differences in the
variability of the measures.
As a manipulation check, an ANOVA with MUS as the
between-subject variable and type of trial (neutral vs.
symptom) as the within-subject variable was used with
(un)pleasantness of the trial as the dependent variable.
Repeated measures ANOVAs were executed with moment of
measurement as the within-subject variable (baseline,
neutral, and symptom trial) and MUS as the between-subject
variable, and the total score of the Symptom Checklist, state-
NA, state-PA, and state-anxiety as dependent variables. For
the neutral and the symptom trial separately, we investigated
the course of subjective and physiological data over the
different phases (expressed as mean and S.D.). To this end,
we carried out ANOVAs with MUS as the between-subject
variable and phase (baseline, rebreathing, and recovery
phase) as the within-subject variable. The dependent
variables were mean and standard deviation of FetCO2,
MV, and concurrently perceived sensations. Further, we
determined possible MUS-related differences in physiologi-
cal data by use of an ANOVA with MUS as the between-
subject variable and type of trial (neutral, symptom) as the
within-subject variable.
Baseline data were not included in the analysis of IA. For
the neutral trial as well as for the symptom trial, ANOVAs
were performed on the Fisher Z correlations between the
concurrent sensation (intensity of breathing, dyspnea) and
each of the physiological referents (FetCO2, MV) with MUS
as a between-subject variable. This was done for the
rebreathing phase and recovery phase separately. An
exception concerns the relationship between the concurrent
sensation and FetCO2 in the recovery phase. Unlike for the
other parameters, the course of FetCO2 in the recovery phase
was not linear. To obtain a more detailed picture of the course
of FetCO2 and the concurrent sensations during the recoveryphase, we divided this phase into five equal time segments of
30 s each. Two repeated measures ANOVAs were performed
on mean FetCO2 and mean concurrent sensation (intensity of
breathing, dyspnea) as the dependent variables, with MUS as
the between-subject variable and time segment (five levels)
of the recovery phase as the within-subject variable. The
results of these two ANOVAs were compared concerning
possible MUS-related differences.
Presentation order of the trials was added as a between-
subject variable to all analyses. Greenhouse–Geisser correc-
tions were applied when appropriate and corrected degrees
of freedom are reported. Follow-up comparisons between
groups were made with either a priori tests or Tukey HSD a
posteriori tests. The α for all analyses was set at .05.Results
Manipulation check and questionnaires
There were no relevant effects of the presentation order of
the trials, neither on physiological data and online subjective
ratings nor on the measures of IA. Overall, the symptom trial
Fig. 2. IA in the recovery phase with minute ventilation as the physiological
referent. Separate ANOVAs were performed for the neutral trial and the
symptom trial. Whiskers denote standard errors of means.
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=11.22; Pb.01; ηp
2=.14], which indicates a successful
manipulation of the information frame. There were no
MUS-related effects on the perceived unpleasantness of the
trial. Information about MUS-related differences in (retro-
spective) symptom reporting (measured by the state
Symptom Checklist), state-NA, state-PA, and state-anxiety
can be found in Table 1.
MUS-related differences in physiological and
subjective data
Physiology
MUS-related effects for FetCO2 and MV (mean and S.D.)
were absent in all phases of all trials.
Concurrent sensations
No MUS-related differences in subjective ratings (mean
and S.D.) were found for the neutral trial. Also, the standard
deviations of the dyspnea rating in the symptom trial were
equal in both MUS groups. However, dyspnea ratings were
overall higher in high compared to low MUS persons [F
(1,70)=5.50; Pb.05; ηp
2=.07], but this was more pronounced
in the recovery phase [MUS×Phase interaction, F
(1.91,133.86)=8.00; Pb.01; ηp
2=.10; Tukey test in the
recovery phase, Pb.05].Fig. 1. IA in the rebreathing phase with minute ventilation (A) and
FetCO2 (B) as the physiological referent. Separate ANOVAs were
performed for the neutral trial and the symptom trial. Whiskers denote
standard errors of means.Within the high symptom reporters group, mean dyspnea
rating was significantly lower during baseline compared to
the rebreathing and the recovery phase (Pb.001). In addition,
mean dyspnea rating in the recovery phase was higher than
that in the rebreathing phase (Pb.001). Within the group of
the low symptom reporters, the mean dyspnea rating was
also significantly lower during baseline compared to the
rebreathing and the recovery phase (Pb.001), but the latter
two did not differ.
Accuracy data
Rebreathing phase
With MV as the physiological referent, no MUS-related
differences in IA appeared, neither for the neutral trial nor for
the symptom trial (Fig. 1A). With FetCO2 as the physiolo-
gical referent, no MUS-related difference in IA emerged in
the neutral trial. Yet, a marginally significant main effect of
MUS in the symptom trial [F(1,70)=3.73; P=.057; ηp
2=.05]
showed that high MUS participants tended to be overall less
accurate in the rebreathing phase of the symptom trial than
low MUS participants (Fig. 1B).
Recovery phase
Taking MV as the physiological referent, no MUS-
related effects for the neutral trial emerged, whereas during
the symptom trial, high MUS participants were signifi-
cantly less accurate compared to low MUS participants
(Fig. 2) [F(1,70)=9.31; Pb.01; ηp
2=.12].
Taking FetCO2 as the physiological referent, two repeated
measures ANOVAs were performed on mean FetCO2 and
mean subjective online rating as the dependent variables,
with MUS as the between-subject variable and time segment
(five levels) of the recovery phase as the within-subject
variable. High and low MUS participants did not differ in
mean FetCO2 during the recovery phase, neither for the
neutral trial nor for the symptom trial (Fig. 3, left panels).
MUS-related differences in mean dyspnea ratings did not
appear for the neutral trial either (Fig. 3, upper right panel).
However, high MUS persons reported significantly higher
Fig. 3. Comparison of MUS effects for mean FetCO2 and mean subjective rating in the recovery phase of the neutral trial (upper panels) and the symptom trial
(lower panels). Mean subjective rating refers to mean intensity of breathing in the neutral trial and to mean dyspnea in the symptom trial. Vertical bars denote 0.95
confidence intervals.
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the recovery phase of the symptom trial [main effect of
MUS: F(1,70)=12.01; Pb.01; ηp
2=.15]. A marginally
significant interaction effect between MUS and time
segment for mean dyspnea ratings of the symptom trial
[F(1.46,102.05)=3.15; P=.06; ηp
2=.04] suggested that the
MUS-related difference in mean dyspnea ratings became
stronger further along the recovery phase, with significant
effects for all moments of measurement except for the first
time segment (the first 30 s of the recovery phase) (Fig. 3,
lower right panel).Discussion
In this study, we used the Standard Rebreathing Test to
investigate the effect of a neutral versus symptom informa-
tion frame on IA and on retrospective symptom reporting in
nonclinical high and low MUS reporters. Given the fact that
IAs computed for both frames were composed of different
subjective rating scales, direct comparison between both
frames was not allowed. Nevertheless, results of the separate
analyses show no MUS-related difference in IA when
physiological changes were induced in a neutral context,
but when the same physiological sensations were induced in
a context referring to symptoms, high symptom reporters
were less accurate compared with low symptom reporters.This MUS effect was most pronounced in the recovery
phase, that is, when the physiological changes were
gradually subsiding. High symptom reporters also had
more retrospective complaints than low symptom reporters,
especially in the symptom trial.
Our findings are in line with the assumption of a reference
to symptoms being the triggering cue for schema activation
in high MUS persons [21,22]. The absence of MUS-related
differences in peripheral physiology adds to the conclusion
that the cause for the elevated symptom level in high MUS
persons should be situated at the level of the central nervous
system rather than at the level of the peripheral physiology.
Further studies need to clarify whether MUS can be
conceived of as “phantom” symptoms or somatovisceral
illusions, in that central nervous representations of inter-
oceptions may be activated by contextual cues without actual
involvement of the peripheral physiology.
In our study, reduced IA in high symptom reporters was
most pronounced in the recovery phase of the symptom trial.
This result can be explained by Brown's assumption [22] of
an attentional process that — along with the memorial,
schematic aspect — underlies the origin of MUS. In this
theory, hierarchical lower-level processes crudely process
the sensory aspects of incoming stimuli, allowing schema
activation in the presence of triggering cues. This feedfor-
ward automatic and preconscious system has the potential to
prevent or disrupt slower, cognitive-controlled processing,
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presumably located in the prefrontal cortex (PFC). In
addition, a repetitive redirection of attention onto schema-
consistent cues by the SAS predicts an attentional disen-
gagement problem in high MUS reporters once these cues
are encountered [22], leading to stronger biasing effects on
IA in the phase following a symptom induction. Indeed, our
results indicate that the subjective ratings of high MUS
persons remained elevated in the recovery phase of the
symptom frame trial, in contrast with low MUS persons.
These findings are in line with previous research, finding
a longer persistence of symptoms in irritable bowel
syndrome (IBS) patients at the end of rectal distension
compared with controls [29]. Karsdorp et al. [30] demon-
strated that high trait anxious patients with congenital heart
disease prime heart-related cues at a preconscious level and
show an increased difficulty shifting attention away from
heart-related sensations. Moreover, fMRI studies in patients
with IBS have recently shown a decrease in ACC activity
and a reduced lateral PFC response during rectal distension.
Both brain regions are assumed to play a role in the
inhibitory top–down control on automatic lower-level
processes [31–34].
The pattern of biases during attentional processing of
subjective sensations may differ in MUS, depending on the
stage of information processing. In the anxiety domain,
Koster et al. [35] found that, at an early stage, high trait
anxious persons more strongly engaged their attention with
and showed impaired disengagement from highly threaten-
ing pictures than low anxious persons. On the other hand,
high anxious individuals showed a stronger tendency to
attentional avoidance of threat at a longer threat presentation
duration. At the less automatic stages of processing, an
avoidant processing style would prevent in-depth processing
and adequate specification of the available information and
would therefore cause more vulnerability to biasing
influences from schema-related cues. Overgeneral proces-
sing and/or retrieving of somatic information could then
be related to the increased retrospective symptom repor-
ting we found in high MUS persons, especially in the
triggering context.
When people report somatic complaints retrospectively,
they depend on their memory. Schema-driven processes are
probably even more likely to occur when remembering
bodily sensations as compared to when perceiving them, as
memorial processes have a reconstructive character. Houtv-
een and Oei [36] demonstrated that retrospective symptom
reports in high MUS persons increased over time. They
attributed this finding to a shift in memory retrieval strategy
from using episodic (specific, personal) to using semantic
(unspecific, schema-related) information. This MUS-related
recall bias was most apparent in the case of vague (as
opposed to localized) symptoms. Moreover, the results of a
traveler's vaccination study showed that biased symptom
reporting did not occur in highly specific or immediate
symptoms, but rather when the physical effects were eithermore vague or delayed [37]. Indeed, in our own study, the
MUS-related effect became stronger the further along the
recovery phase and when reporting the symptoms
retrospectively.
This study has some limitations. First, the classification of
participants into high MUS persons is based on their scores
on a symptom checklist and on their self-reported claim that
a GP or specialist could find no objective cause for their
symptoms after clinical evaluation. However, no additional
extensive somatic investigation was performed. Second, our
sample was confined to women only. Gender-related
differences exist in symptom reporting [38], symptom
perception processes [39], and stress physiology [40] and
should be further investigated. Nevertheless, previous
research has shown that MUS are more common in females
than in males [41,42]. Third, we drew our participants from a
rather homogeneous population of young, nonclinical
students. We believe that in the subclinical and clinical
MUS population, the same biasing mechanisms apply, be it
in a more magnified form. Nevertheless, future studies
should clarify whether the present findings are generalizable
to other populations (e.g., older people with varying SES and
MUS patient groups). Neuroimaging studies may also
further examine possible central abnormalities in high
MUS reporters.
In sum, physiological responses experienced in a
symptom information frame appear to trigger a memory
schema, activating a processing bias in high symptom
reporters. This causes a substantial decrease in IA, which is
most pronounced when the physiological responses have a
low intensity. Because most medical examinations, by
definition, trigger a symptom information frame while
causing low-intensity physiological responses, our findings
suggest that symptom reports of high MUS persons in such
situations do not accurately reflect responses of the body.
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